ScoreHaematology

DIPSS and DIPSS-plus in primary myelofibrosis

Estimates risk and median survival in primary myelofibrosis at any time during the disease course.

Updated 30 October 2026

When to use it

Primary myelofibrosis, at diagnosis or during follow-up, to assess prognosis and eligibility for allogeneic transplant.

What it needs

  • Age > 65 yearsYes or no
  • Haemoglobin < 10 g/dLYes or no
  • White cells > 25 × 10⁹/LYes or no
  • Peripheral blood blasts ≥ 1 %Yes or no
  • Constitutional symptoms (weight loss > 10 % in 6 months, night sweats, fever > 37.5 °C)Yes or no
  • Platelets < 100 × 10⁹/LYes or no
  • Red cell transfusion dependenceYes or no
  • Unfavourable karyotypeYes or no

The points for each answer and the automatic total are in the app.

How to interpret it

DIPSS score
ResultInterpretation
≤ 0Low risk (median not reached)
1–2Intermediate-1 risk (median ≈ 14 years)
3–4Intermediate-2 risk (median ≈ 4 years)
≥ 5High risk (median ≈ 1.5 years)

In the app it also calculates: DIPSS-plus score.

Practical tip

Unlike the IPSS, the DIPSS is “dynamic”: it can be recalculated when new factors appear during follow-up.

3 more practical tips in the app.

Reference

A support tool for healthcare professionals: it guides and does not replace clinical judgement.

Back to top